There is increasing evidence that central noradrenaline (NA) transport mechanisms are implicated in the central nervous system complications of acute liver failure. In order to assess this possibility, binding sites for the high affinity NA transporter ligand [
INTRODUCTION
Accumulating evidence suggests that central noradrenergic mechanisms may be implicated in the pathogenesis of the central nervous system complications of acute liver failure. Studies in several animal models of acute liver failure including hepatectomy (Hadesman et al., 1995 , Tyce and Owen, 1978 and Herlin et al., 1983 , liver devascularization (Murakami et al., 1992) and thioacetamide-induced liver injury (Yurdaydin et al., 1990) in the rat have consistently shown decreases in brain tissue concentrations of noradrenaline (NA). Moreover, hepatectomy results in increased NA release in ventriculocisternal perfusates (McKinzie et al., 1996) and in vivo microdialysis studies have shown that liver devascularization results in increased extracellular brain concentrations of NA as a function of the severity of encephalopathy (Michalak et al., 1998) . These latter two findings could be the consequence of impaired high affinity uptake of NA into neural cells. The present study, therefore, was initiated to assess the integrity of high affinity NA transport sites in relation to extracellular NA concentrations in the brains of rats with acute liver failure due to hepatic devascularization. Michalak 
MATERIALS AND METHODS

Surgical techniques
Male Sprague-Dawley rats (Charles River, St. Constant, Que., Canada) weighing 175-200 g at the time of surgery, were anesthetized with halothane, and an end-to-side portacaval anastomosis was performed as previously described (Michalak et al., 1996) . The inferior vena cava was partially clamped, and an elliptical piece of vein was removed. The portal vein was ligated, cut and an end-to-side anastomosis (shunt: SH) was performed under a dissecting microscope, according to the guidelines of Lee and Fisher (1961) . Total surgery time was ∼15 min. Sham-operated animals (matched for weight) were similarly anesthetized and, following laparotomy, the inferior vena cava and portal vein were clamped for 15 min (sham: SM). After surgery, the animals had free access to standard laboratory food and water. All rats were housed under constant conditions of temperature, humidity and light cycles. (Paxinos and Watson, 1982) ). The guide cannula was closed with a dummy probe and secured in place with dental acrylic. Total surgery time was ∼15 min. Throughout the surgical procedure, the temperature of animals was maintained at 37°C (CMA/150 temperature controller). Following recovery from anesthesia, rats were maintained in microdialysis chambers (CMA/120 system for freely-moving animals) with free access to rat chow and water.
24 h after intracerebral guide cannula implantation (i.e., 48 h after shunt or sham surgery), rats were reanesthetized (halothane) and subjected to hepatic artery ligation (HAL) or laparotomy (SM). The dummy probe was removed from the intracerebral guide cannula and a microdialysis probe (CMA/12: 2 mm long, 0.5 mm diameter) was inserted into frontal cortex of freely-moving animals. Aortic and peritoneal catheters were implanted in all animals for arterial glucose monitoring, and 5% glucose (or 0.9% NaCl for control animals) was administered as needed.
Four groups of rats were thus created: liver ischemia (SH + HAL) and the three obligate control groups (SH + SM, SM + HAL, SM + SM). Separate groups of rats were used for microdialysis and autoradiographic studies. Animals for the autoradiographic study were treated as described earlier without the intracerebral guide cannula implantation. All animals were evaluated every 30 min following the second surgery.
Measurement of NA in microdialysates
NA concentrations were measured at precoma and coma stages of encephalopathy in acute liver failure rats and at equivalent time points in microdialysates (described earlier). NA concentrations were measured by HPLC with electrochemical detection as previously described (Michalak et al., 1998) .
[ 3 H]-nisoxetine autoradiography
Rats were killed by decapitation and brains rapidly removed and placed in iced propanol then stored at −70°C until sectioning. Sagittal sections of brains from the four groups of animals described earlier were sectioned at 20 μm, mounted on gelatin-coated slides and stored at −20°C until use. using an image analyzer (MCID system, St. Catherines, Ont., Canada). Specific binding was calculated as the difference between specific and non-specific binding. [ 3 H]-standards were used to convert optical density measurements to binding sites densities expressed as pmol/g tissue.
Statistical analyses
Data are expressed as mean ± SEM values from at least five animals per group. Differences were compared using one-way ANOVA (Tukey-Kramer multiple comparisons test) and a p value of <0.05 was considered significant.
RESULTS
Rats with hepatic devascularization manifested a reproducible sequence of neurological impairment which progressed through diminished spontaneous activity followed by loss of righting ability (defined as the precoma stage) and ultimately loss of corneal reflex (coma). Rats from the three control groups showed no such neurological deterioration.
A typical autoradiogram showing [
3 H]-nisoxetine sites in a mid-sagittal section from a control animal is shown in Fig. 1 . Of particular note was the relatively high densities of [ 3 H]-nisoxetine sites in dentate gyrus of the hippocampus as well as in thalamus and hypothalamus. This distribution of [ 3 H]-nisoxetine sites in control brains was comparable to that previously published by others (Bauer and Tejani-Butt, 1992 Measurement of extracellular (microdialysate) concentrations of NA in frontal cortex of rats with acute liver failure revealed a significant (46%) increase at coma stages of encephalopathy (Table 2) . 
DISCUSSION
The NA transporter is an antidepressant-sensitive electrogenic transporter located on the plasma membrane of noradrenergic neurons (Lorang et al., 1994) . It is responsible for removal of NA from the extracellular milieu of brain via an iondependent transport process (Harder and Bonisch, 1985) and, in this way, terminates the action of NA in the synapse. The study of NA transporter regulation is nowadays facilitated by the availability of the high affinity ligand [ 3 H]-nisoxetine which binds to a single class of sites in the rat brain (Tejani-Butt, 1992) .
Results of the present study reveal a selective loss of [ 3 H]-nisoxetine sites in frontal cortex and thalamus at coma stages of encephalopathy in rats with acute liver failure. The finding of decreased transporter sites in frontal cortex of rats with acute liver failure due to hepatic devascularization offers a cogent explanation for the findings in a previous (and the present) study of increased NA concentrations in brain extracellular fluid of these animals at coma stages of encephalopathy (Michalak et al., 1998) . Similar mechanisms could be implicated in hepatectomized rats in which significant increases of NA were described in ventriculocisternal perfusates (McKinzie et al., 1996) . Whether or not the loss of thalamic transporter sites leads to increased extracellular NA awaits further studies.
The mechanism whereby acute liver failure results in down-regulation of NA transporter sites is not known. One possibility could involve NA itself. Previous studies reveal that treatment of rats with monoamine oxidase inhibitors, which results in increased intracellular NA, leads to increased NA transporter sites (Lee et al., 1983) whereas depletion of brain NA following reserpine administration leads to reduced NA transporter sites. It is of interest in this regard that acute liver failure in both hepatectomized and liver devascularized rats results in decreased brain NA concentrations (Tyce and Owen, 1978 , Herlin et al., 1983 , Murakami et al., 1992 and Hadesman et al., 1995 , suggesting that the decreased transporter sites could be the consequence of a depletion of intracellular stores of NA in the brains of these animals. Furthermore, depletion of monoamine stores has previously been demonstrated following exposure of rat brain synaptosomes to millimolar concentrations of ammonia (Erecinska et al., 1987) , similar to that reported in the brains of rats with ischemic liver failure (Swain et al., 1992) .
Alterations in the synaptic availability of NA has been shown to contribute to neuropsychiatric disorders and encephalopathy. For example, evidence of altered central noradrenergic function has been described in patients with endogenous depression (Lechin et al., 1995) and drugs which bind to and inhibit the NA transporter are effective antidepressants (Barker and Blakely, 1995) . Decreased brain concentrations of NA have also been described in the forebrain of rats with experimental septic encephalopathy (Kadoi et al., 1996) . Treatment of cirrhotic patients with the adrenergic antagonist propranolol may precipitate encephalopathy in these patients (Tarver et al., 1983 and Weisner , 1986) and while this latter phenomenon has generally been attributed to a peripheral action of propranolol, central adrenergic mechanisms cannot be excluded. Administration of noradrenergic receptor antagonists to experimental animals results in delayed acquisition of motor tasks (Heron et al., 1996) . A previous study showed a selective loss of α and β noradrenergic receptor sites in brains of rats with acute liver failure (Michalak et al., 1998) where loss of adrenergic sites was restricted to frontal cortex and thalamus, brain regions shown, in the present study, to express decreased amounts of NA transporter sites in acute liver failure. Together, these findings suggest that acute liver failure may result in a deficit in central NA synaptic regulation. Such changes could be implicated in the neuropsychiatric and cognitive symptoms characteristic of hepatic encephalopathy in patients with acute liver failure.
The hepatic devascularized rat manifests severe brain edema at coma stages of encephalopathy (Blei et al., 1992) . Brain edema in these animals, as in human acute liver failure, is cytotoxic in nature and is characterized by cytoplasmic swelling of astrocytic processes (Norenberg, 1994 and Ganz et al., 1989) . Such alterations in astrocyte morphology could also be the consequence of altered NA transport and receptor function. Astrocytes express noradrenergic receptors both in vitro and in situ (Shao and Sutin, 1992) and cortical astrocytes in vitro express [ 3 H]-nisoxetine binding sites which are significantly reduced by exposure to ammonia in concentrations equivalent to those encountered in brain in acute liver failure (Hazell and Butterworth, unpublished data). Exposure of cultured cortical astrocytes to these concentrations of ammonia leads to significant cell swelling (Norenberg, 1987) . A previous study showed that depletion of brain NA by 6-hydroxydopamine administration resulted in significant brain edema in experimental ischemic rats (Kobayashi et al., 1990) and earlier studies in several animal models of acute liver failure reveal similarly decreased brain tissue concentrations of NA (Hadesman et al., 1995 , Murakami et al., 1992 and Yurdaydin et al., 1990 . Together with the results of the present study, these findings suggest that alterations of NA transport may be implicated in the pathogenesis of brain edema in acute liver failure. Further studies are required in order to assess this possibility.
